Roche (RHHBY) News Today $40.80 -0.08 (-0.20%) As of 03:54 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartDividendHeadlinesInsider TradesOwnershipShort InterestBuy This Stock RHHBY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Financial Survey: Roche (OTCMKTS:RHHBY) vs. Sanofi (NASDAQ:SNY)August 27 at 3:03 AM | americanbankingnews.comF. Hoffmann-La Roche Ltd: Roche's US subsidiary Genentech breaks ground on state-of-the-art manufacturing facility in North Carolina, USAAugust 25, 2025 | finanznachrichten.deRoche’s US subsidiary Genentech breaks ground on state-of-the-art manufacturing facility in North Carolina, USAAugust 25, 2025 | finance.yahoo.comGenentech and Roche Break Ground on State-of-the-Art Manufacturing Facility in Holly Springs, North CarolinaAugust 25, 2025 | businesswire.comRoche's US subsidiary Genentech breaks ground on state-of-the-art manufacturing facility in North Carolina, USAAugust 25, 2025 | globenewswire.comCorient IA LLC Takes Position in Roche Holding AG (OTCMKTS:RHHBY)August 19, 2025 | marketbeat.comRoche (OTCMKTS:RHHBY) & Innoviva (NASDAQ:INVA) Head-To-Head ComparisonAugust 18, 2025 | americanbankingnews.comFCA Corp TX Invests $494,000 in Roche Holding AG (OTCMKTS:RHHBY)August 16, 2025 | marketbeat.comPharma tariff announcement likely ‘weeks away,’ Reuters reportsAugust 14, 2025 | msn.comH.C. Wainwright doubles Insmed target to $240 on ‘pipeline-in-a-pill’ potentialAugust 13, 2025 | msn.comHC Wainwright Doubles Price Target On Insmed After Brinsupri Approval: Retail Expects Stock To Hit $150 By End Of WeekAugust 13, 2025 | msn.comRoche, Novartis due to meet Swiss govt. amid Trump’s tariff threats: ReutersAugust 11, 2025 | msn.comSwiss leaders to discuss tariff situation with Roche, Novartis, Bloomberg saysAugust 11, 2025 | msn.comEverett Harris & Co. CA Makes New $445,000 Investment in Roche Holding AG (OTCMKTS:RHHBY)August 10, 2025 | marketbeat.comRoche Holding AG (OTCMKTS:RHHBY) Receives Average Recommendation of "Moderate Buy" from BrokeragesAugust 9, 2025 | marketbeat.comSA Asks: How could Trump's drug pricing demands impact stocks?August 8, 2025 | msn.comTrump administration reportedly seeks higher ex-US drug prices in pursuit of MFN policyAugust 8, 2025 | msn.comRoche’s Susvimo maintains vision over five years with two refills per year in people with neovascular age-related macular degeneration (nAMD)August 1, 2025 | finance.yahoo.comGenentech's Susvimo Maintains Vision Over Five Years With Two Refills Per Year in People With Wet Age-Related Macular Degeneration (AMD)August 1, 2025 | businesswire.comRoche's Susvimo maintains vision over five years with two refills per year in people with neovascular age-related macular degeneration (nAMD)August 1, 2025 | globenewswire.comAnalyst Report: Roche Holding AGJuly 30, 2025 | finance.yahoo.comRoche Holding AG’s Earnings Call Highlights Growth and ChallengesJuly 30, 2025 | theglobeandmail.comDZ BANK AG Reaffirms Their Buy Rating on Roche Holding AG (RHHVF)July 28, 2025 | theglobeandmail.comGenentech to present new data from Alzheimer’s development portfolioJuly 28, 2025 | msn.comEU-US trade deal could add up to $19 billion in pharma industry costs, analysts sayJuly 28, 2025 | reuters.comRoche plans to test if new medicine can prevent AD symptoms, Bloomberg saysJuly 28, 2025 | msn.comGenentech and Roche Present New Insights in Alzheimer's Disease Research Across Its Diagnostics and Pharmaceutical Portfolios at AAICJuly 28, 2025 | businesswire.comRoche presents new insights in Alzheimer's disease research across its diagnostics and pharmaceutical portfolios at AAICJuly 28, 2025 | globenewswire.comRoche to test if new drug can prevent Alzheimer's disease, Bloomberg News reportsJuly 27, 2025 | reuters.comEU panel declines backing Sarepta-Roche gene therapy for DuchenneJuly 25, 2025 | msn.comRoche Holding AG (RHHBY) Q2 2025 Earnings Call TranscriptJuly 25, 2025 | seekingalpha.comRoche pauses Sarepta gene therapy shipments outside the U.S.July 24, 2025 | msn.comRoche eyes direct-to-patient sales in U.S. to avoid pharma middlemenJuly 24, 2025 | msn.comRoche: Q2 Earnings - Pipeline Setbacks And U.S. Pressures Undermine Solid ResultsJuly 24, 2025 | seekingalpha.comRoche Diagnostics showcases science-driven leadership and innovation at ADLM 2025July 24, 2025 | prnewswire.comRoche Holding AG: Hold Rating Amid Mixed Financial Signals and Strategic ChallengesJuly 24, 2025 | tipranks.comRoche considering selling drugs directly to US patients, CEO saysJuly 24, 2025 | reuters.comRoche confirms guidance as H1 core operating profit up 6%July 24, 2025 | reuters.com[Ad hoc announcement pursuant to Art. 53 LR] Roche continues strong momentum with 7% growth (CER) in the first half of 2025July 24, 2025 | globenewswire.comThe Roche Associates, Inc. Named “Top Senior Living Marketing Agency 2025”July 23, 2025 | globenewswire.comEuropean Commission approves Roche’s Itovebi for people with ER-positive, HER2-negative, advanced breast cancer with a PIK3CA mutationJuly 23, 2025 | finance.yahoo.comRoche receives CE Mark for minimally invasive blood test to help rule out Alzheimer's diseaseJuly 23, 2025 | globenewswire.comEuropean Commission approves Roche's Itovebi for people with ER-positive, HER2-negative, advanced breast cancer with a PIK3CA mutationJuly 23, 2025 | globenewswire.comEWL: Buy Swiss, Invest GloballyJuly 22, 2025 | seekingalpha.comRoche’s Board of Directors proposes exchange of Genussscheine for participation certificates (Partizipationsscheine)July 22, 2025 | uk.finance.yahoo.comSarepta pares gains as report suggests an ‘arduous’ path for Duchenne drugJuly 22, 2025 | msn.comRoche pauses shipments of Elevidys gene therapy outside the US, Bloomberg News reportsJuly 22, 2025 | reuters.comRoche's Board of Directors proposes exchange of Genussscheine for participation certificates (Partizipationsscheine)July 22, 2025 | globenewswire.comRoche COPD biologic astegolimab fails in phase 3 for COPDJuly 21, 2025 | msn.com[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on astegolimab in chronic obstructive pulmonary diseaseJuly 21, 2025 | globenewswire.com Get Roche News Delivered to You Automatically Sign up to receive the latest news and ratings for RHHBY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RHHBY Media Mentions By Week RHHBY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RHHBY News Sentiment▼0.001.03▲Average Medical News Sentiment RHHBY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RHHBY Articles This Week▼58▲RHHBY Articles Average Week Get the Latest News and Ratings for RHHBY and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Roche and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies China Construction Bank News Airbus Group News EssilorLuxottica News Nintendo News Iberdrola News BNP Paribas News Vinci News Atlas Copco News Bayerische Motoren Werke News Compass Group News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:RHHBY) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roche Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Roche With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access